Demographic and clinical data of IPA and non-IPA patients.

Abbreviations: NS, non-significant. HSCT: Hematopoietic stem cell transplantation, AML: acute myeloid leukemia, ALL: acute lymphoid leukemia, MM: Multiple Myeloma, CML: chronic myeloid leukemia, HL: Hodgekin's lymphoma, NHL: non-Hodgekin's lymphoma, AA: Aplastic anemia, CLL: chronic lymphocytic leukemia, MDS: myelodysplastic syndrome.†: Severe neutropenia was defined as absolute neutrophil count 3 for a period of more than 12 days. GVHD: graft versus host disease;‡: p-values were calculated by student-t test for continous- and Fishers exact test for binary data.缩略语说明： NS：无统计学意义（non-significant）； HSCT：造血干细胞移植（Hematopoietic stem cell transplantation）； AML：急性髓系白血病（acute myeloid leukemia）； ALL：急性淋巴细胞白血病（acute lymphoid leukemia）； MM：多发性骨髓瘤（Multiple Myeloma）； CML：慢性髓系白血病（chronic myeloid leukemia）； HL：霍奇金淋巴瘤（Hodgkin's lymphoma，原文原拼写为Hodgekin's lymphoma，采用标准医学译法）； NHL：非霍奇金淋巴瘤（non-Hodgkin's lymphoma）； AA：再生障碍性贫血（Aplastic anemia）； CLL：慢性淋巴细胞白血病（chronic lymphocytic leukemia）； MDS：骨髓增生异常综合征（myelodysplastic syndrome）。 †：重度中性粒细胞减少症定义为绝对中性粒细胞计数为3且持续时长超过12天。 GVHD：移植物抗宿主病（graft versus host disease）； ‡：连续型数据采用t检验计算P值，二分类数据采用Fisher精确检验计算P值。